Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

21 mai 2026 05h11 HE | Source: Research and Markets

Next Generation Immune Checkpoint Inhibitors Market Report 2026-2035: Pipeline Features ~475 Therapy Programs, Emphasizing on Enhanced Pathway Modulation to Deliver Sustained Therapeutics in Oncology

Dublin, May 21, 2026 (GLOBE NEWSWIRE) -- The "Next Generation Immune Checkpoint Inhibitors Market (2nd Edition), by Target Immune Checkpoint, Target Disease Indication, Type of Molecule,...
14 mai 2026 09h39 HE | Source: Research and Markets

PD-L1 X 4-1BB (CD137) Bispecific Antibodies Pipeline Competitor Analysis Report 2026: Active R&D Programs by R&D Phase and Profile of Bispecific Antibodies by Drug Modality

Dublin, May 14, 2026 (GLOBE NEWSWIRE) -- The "Pipeline of PD-L1 x 4-1BB (CD137) Bispecific Antibodies" report has been added to ResearchAndMarkets.com's offering.This competitive intelligence...
14 mai 2026 09h37 HE | Source: Research and Markets

CD40 Agonists and CD40/L Antagonists Pipeline Competitor Analysis Report 2026: Active R&D Programs by R&D Phase and Profile of Agonists and Antagonists by Drug Modality

Dublin, May 14, 2026 (GLOBE NEWSWIRE) -- The "Pipeline of CD40 Agonists and CD40/L Antagonists" report has been added to ResearchAndMarkets.com's offering.This competitive intelligence report about...
14 mai 2026 09h19 HE | Source: Research and Markets

CD73 Inhibitors Pipeline Competitor Analysis Report 2026: Active R&D Programs by R&D Phase and Profile of Inhibitors by Drug Modality

Dublin, May 14, 2026 (GLOBE NEWSWIRE) -- The "Pipeline of CD73 Inhibitors" report has been added to ResearchAndMarkets.com's offering.This competitive intelligence report about CD73 Inhibitors...
14 mai 2026 07h45 HE | Source: Research and Markets

C-Met-Targeted Immunotherapies Pipeline Competitive Intelligence Report 2026: CCR8-targeted R&D Programs and Profile of CCR8-targeted Immunotherapies by Drug Modality

Dublin, May 14, 2026 (GLOBE NEWSWIRE) -- The "Pipeline of c-Met-Targeted Immunotherapies" report has been added to ResearchAndMarkets.com's offering.This competitive intelligence report about...
24 avr. 2026 05h44 HE | Source: Research and Markets

Oncology Clinical Trials Research Report 2026: $20+ Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

Dublin, April 24, 2026 (GLOBE NEWSWIRE) -- The "Oncology Clinical Trials Market Report 2026" has been added to ResearchAndMarkets.com's offering. The oncology clinical trials market has seen...
13 avr. 2026 05h51 HE | Source: Research and Markets

Antibody Drug Conjugates (ADC) Market Research and Competitive Landscape Report 2026 - Extensive Analysis of Over 180 Companies and More Than 290 Drugs

Dublin, April 13, 2026 (GLOBE NEWSWIRE) -- The "Antibody Drug Conjugates - Competitive Landscape, 2026" has been added to ResearchAndMarkets.com's offering. The competitive landscape report...
13 avr. 2026 05h11 HE | Source: Research and Markets

Oncolytic Virus Market Competitive Landscape Report 2026: Detailed Insights Into 100+ Companies and 110 Drugs

Dublin, April 13, 2026 (GLOBE NEWSWIRE) -- The "Oncolytic Virus - Competitive Landscape, 2026" has been added to ResearchAndMarkets.com's offering.This comprehensive report offers detailed insights...
02 avr. 2026 11h31 HE | Source: Research and Markets

Tumor Microenvironment Market to Reach Over $2.7 Billion by 2030 - Rising Demand for Personalized Oncology Therapies and Next-Gen Immunotherapies Driving the Industry

Dublin, April 02, 2026 (GLOBE NEWSWIRE) -- The "Tumor Microenvironment Market Report 2026" has been added to ResearchAndMarkets.com's offering. The tumor microenvironment (TME) market has...
30 mars 2026 04h58 HE | Source: Research and Markets

Oncology Biomarkers Market Trends and Investment Opportunities Report 2026-2030: Global, Regional and Country-Level Outlook

Dublin, March 30, 2026 (GLOBE NEWSWIRE) -- The "Oncology Biomarkers Market Report 2026" has been added to ResearchAndMarkets.com's offering. The report provides comprehensive insights into market...

Page suivante